mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.06 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.06 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.06 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.07 |